シーケンス試薬市場：技術、タイプ、用途、エンドユーザー別-2025-2030年の世界予測

シーケンス試薬市場は、2023年に51億7,000万米ドルと評価され、2024年には55億8,000万米ドルに達すると予測され、CAGR 10.23%で成長し、2030年には102億4,000万米ドルに達すると予測されています。

シーケンス試薬市場には、DNA、RNA、または特定のタンパク質を分析する目的でシーケンス反応に使用される化学物質が幅広く含まれています。これらの試薬は、ゲノムおよびプロテオミクス研究、バイオテクノロジー、個別化医療のアプリケーションにおいて極めて重要です。これらの試薬の必要性は、個別化医療に対する需要の増加、ゲノミクスの進歩、遺伝性疾患の増加から生じており、これらすべてが正確なDNA配列決定プロセスを求めています。主なアプリケーションには、次世代シーケンス（NGS）、サンガーシーケンス、第3世代シーケンスプラットフォームなどがあります。調査対象は、学術・研究機関、製薬・バイオテクノロジー企業、臨床研究機関などのエンドユーザーです。市場の成長は、シーケンシング手法の技術的進歩、ゲノムシーケンスのコスト低下、ゲノミクスにおける研究活動の活発化によって大きく促進され、高度で効率的な試薬の需要が高まっています。個別化医療とリキッドバイオプシー技術の急速な発展が潜在的なビジネスチャンスであり、市場各社は製品ポートフォリオの拡充と試薬の最適化に取り組んでいます。このような機会を捉えるために、企業は試薬の有効性、安定性、使いやすさを革新し、向上させるための研究開発に投資する必要があります。とはいえ、市場はシーケンシング技術の高コスト、複雑な償還シナリオ、遺伝子データの取り扱いに関連する倫理的懸念といった課題に直面しており、これらは成長軌道を阻害する可能性があります。技術革新と研究は、費用対効果の高いシーケンスソリューションの開発、農業および獣医学分野での応用拡大、データ解釈アルゴリズムの強化に向けることができます。さらに、市場参入企業は市場拡大のために戦略的提携やパートナーシップに注力すべきです。競争の激しい市場であるため、成長を維持するためには技術的進歩と規制遵守に継続的に重点を置く必要があります。このダイナミックな情勢を乗り切る上で、企業は競争力を維持するために、進化する技術動向と顧客需要に戦略を合わせることが推奨されます。

市場力学：急速に進化するシーケンス試薬市場の主要市場インサイトを公開

シーケンス試薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 公的機関および民間団体からの資金調達の増加
  • 第3世代シーケンサー技術の採用の増加
  • DNAシーケンシングの低価格化と遺伝性疾患の早期診断需要の高まり
• 市場抑制要因
  • シーケンス法の社会的・倫理的問題に関する懸念
• 市場機会
  • 第3世代シーケンス（TGS）技術に対する需要の高まり
  • シーケンス能力の向上
• 市場の課題
  • 償還に関する有利な政策の欠如

ポーターのファイブフォース：シーケンス試薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：シーケンス試薬市場における外部からの影響の把握

外部マクロ環境要因は、シーケンス試薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析シーケンス試薬市場における競合情勢の把握

シーケンス試薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスシーケンス試薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、シーケンス試薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨シーケンス試薬市場における成功への道筋を描く

シーケンス試薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 公的機関および民間団体からの資金提供の増加
    • 第三世代シーケンシング技術の採用の増加
    • DNAシークエンシングの低価格化と遺伝性疾患の早期診断の需要増加
  • 抑制要因
    • シークエンシング方法の社会的および倫理的問題に関する懸念
  • 機会
    • 第三世代シーケンシング（TGS）技術の需要の高まり
    • シーケンス機能の強化
  • 課題
    • 有利な払い戻しポリシーの欠如
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 シーケンス試薬市場：技術別

• 次世代シーケンシング
• サンガーシーケンス
• 第三世代シーケンシング

第7章 シーケンス試薬市場：タイプ別

• コントロールキット
• ライブラリキット
• シーケンシングキット
• テンプレートキット

第8章 シーケンス試薬市場：用途別

• アグリゲノミクスと法医学
• 臨床調査
• 腫瘍学
• 生殖に関する健康

第9章 シーケンス試薬市場：エンドユーザー別

• 学術調査
• 臨床調査
• 病院・クリニック
• 製薬・バイオテクノロジー企業

第10章 南北アメリカのシーケンス試薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のシーケンス試薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのシーケンス試薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• BGI Genomics Co., Ltd.
• BioChain Institute Inc.
• BioLegend, Inc.
• Bioline by Meridian Bioscience, Inc.
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• LGC Limited
• Merck KGaA
• Oxford Nanopore Technologies PLC
• Pacific Biosciences of California, Inc.
• Standard BioTools Inc.
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• TriLink BioTechnologies by Maravai Life Sciences

LIST OF FIGURES

• FIGURE 1. SEQUENCING REAGENTS MARKET RESEARCH PROCESS
• FIGURE 2. SEQUENCING REAGENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. SEQUENCING REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. SEQUENCING REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SEQUENCING REAGENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SEQUENCING REAGENTS MARKET DYNAMICS
• TABLE 7. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTROL KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIBRARY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUENCING KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TEMPLATE KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY AGRIGENOMICS & FORENSICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CLINICAL INVESTIGATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. CANADA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. CANADA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. CANADA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES SEQUENCING REAGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. CHINA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. CHINA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. CHINA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. CHINA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. INDIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. INDIA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. INDIA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. ITALY SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. ITALY SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ITALY SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. ITALY SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. POLAND SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. POLAND SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. POLAND SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. POLAND SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. QATAR SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. QATAR SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. QATAR SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. QATAR SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM SEQUENCING REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. SEQUENCING REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 195. SEQUENCING REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Sequencing Reagents Market was valued at USD 5.17 billion in 2023, expected to reach USD 5.58 billion in 2024, and is projected to grow at a CAGR of 10.23%, to USD 10.24 billion by 2030.

The sequencing reagents market encompasses a wide array of chemical substances used in sequencing reactions for the purpose of analyzing DNA, RNA, or specific proteins. These reagents are crucial in genomic and proteomic research, biotechnology, and personalized medicine applications. Their necessity arises from the increasing demand for personalized medicine, advancements in genomics, and the rise of genetic disorders, all calling for precise DNA sequencing processes. The primary applications include next-generation sequencing (NGS), Sanger sequencing, and third-generation sequencing platforms. Sequencing reagents serve end-users such as academic and research institutions, pharmaceutical and biotechnology companies, and clinical research entities. Market growth is prominently fueled by technological advancements in sequencing methodologies, declining costs of genome sequencing, and increasing research activities in genomics, bolstering demand for advanced and efficient reagents. Potential opportunities lie in the rapid development of personalized medicine and liquid biopsy technologies, prompting market players to broaden their product portfolios and optimize reagent offerings. To seize these opportunities, companies ought to invest in R&D efforts to innovate and enhance reagent efficacy, stability, and user-friendliness. Nonetheless, the market faces challenges such as high costs of sequencing technologies, complex reimbursement scenarios, and ethical concerns related to genetic data handling, which could impede growth trajectories. Innovation and research can be directed towards developing cost-effective sequencing solutions, expanding applications in agriculture and veterinary fields, and enhancing data interpretation algorithms. Additionally, market players should focus on strategic collaborations and partnerships for market expansion. The market's competitive nature necessitates continuous emphasis on technological advancements and regulatory compliance to sustain growth. In navigating this dynamic landscape, businesses are recommended to align their strategies with evolving technological trends and customer demands to maintain a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Sequencing Reagents Market

The Sequencing Reagents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing funding from public & private entities
  • Growing levels of adoption for third-generation sequencing techniques
  • The Increasing Affordability of DNA Sequencing and Growing Demand for Early Diagnosis of Genetic Disorders
• Market Restraints
  • Concerns related to social and ethical issues of sequencing methods
• Market Opportunities
  • Rising demand for third-generation sequencing (TGS) technologies
  • Enhancement of sequencing capabilities
• Market Challenges
  • Lack of favorable policies of reimbursement

Porter's Five Forces: A Strategic Tool for Navigating the Sequencing Reagents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Sequencing Reagents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Sequencing Reagents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Sequencing Reagents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Sequencing Reagents Market

A detailed market share analysis in the Sequencing Reagents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Sequencing Reagents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Sequencing Reagents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Sequencing Reagents Market

A strategic analysis of the Sequencing Reagents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sequencing Reagents Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BGI Genomics Co., Ltd., BioChain Institute Inc., BioLegend, Inc., Bioline by Meridian Bioscience, Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., LGC Limited, Merck KGaA, Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Standard BioTools Inc., Takara Bio Inc., Thermo Fisher Scientific, Inc., and TriLink BioTechnologies by Maravai Life Sciences.

Market Segmentation & Coverage

This research report categorizes the Sequencing Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Next-Generation Sequencing, Sanger Sequencing, and Third Generation Sequencing.
• Based on Type, market is studied across Control Kits, Library Kits, Sequencing Kits, and Template Kits.
• Based on Application, market is studied across Agrigenomics & Forensics, Clinical Investigation, Oncology, and Reproductive Health.
• Based on End-User, market is studied across Academic Research, Clinical Research, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing funding from public & private entities
    • 5.1.1.2. Growing levels of adoption for third-generation sequencing techniques
    • 5.1.1.3. The Increasing Affordability of DNA Sequencing and Growing Demand for Early Diagnosis of Genetic Disorders
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns related to social and ethical issues of sequencing methods
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising demand for third-generation sequencing (TGS) technologies
    • 5.1.3.2. Enhancement of sequencing capabilities
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of favorable policies of reimbursement
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Sequencing Reagents Market, by Technology

• 6.1. Introduction
• 6.2. Next-Generation Sequencing
• 6.3. Sanger Sequencing
• 6.4. Third Generation Sequencing

7. Sequencing Reagents Market, by Type

• 7.1. Introduction
• 7.2. Control Kits
• 7.3. Library Kits
• 7.4. Sequencing Kits
• 7.5. Template Kits

8. Sequencing Reagents Market, by Application

• 8.1. Introduction
• 8.2. Agrigenomics & Forensics
• 8.3. Clinical Investigation
• 8.4. Oncology
• 8.5. Reproductive Health

9. Sequencing Reagents Market, by End-User

• 9.1. Introduction
• 9.2. Academic Research
• 9.3. Clinical Research
• 9.4. Hospitals & Clinics
• 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Sequencing Reagents Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Sequencing Reagents Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Sequencing Reagents Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. BGI Genomics Co., Ltd.
• 3. BioChain Institute Inc.
• 4. BioLegend, Inc.
• 5. Bioline by Meridian Bioscience, Inc.
• 6. F. Hoffmann-La Roche Ltd.
• 7. Illumina, Inc.
• 8. LGC Limited
• 9. Merck KGaA
• 10. Oxford Nanopore Technologies PLC
• 11. Pacific Biosciences of California, Inc.
• 12. Standard BioTools Inc.
• 13. Takara Bio Inc.
• 14. Thermo Fisher Scientific, Inc.
• 15. TriLink BioTechnologies by Maravai Life Sciences